Healthcare Stocks and ETFs to Watch in 2022
Bayer is evaluating the divestitures of the crop science and consumer healthcare businesses, which appear to hold few synergies with the prescription drug business. According to Modern Healthcare, healthcare prices in general should rise by 3.6% dans 2022 and boost overall healthcare spending growth 4.6% pour $4.5 trillion. These companies create drugs and treatments for